期刊文献+
共找到171篇文章
< 1 2 9 >
每页显示 20 50 100
Stem cell therapy:A promising therapeutic approach for skeletal muscle atrophy
1
作者 Ying-Jie Wang Ze-Hao Chen +5 位作者 Yun-Tian Shen Ke-Xin Wang Yi-Min Han Chen Zhang Xiao-Ming Yang Bing-Qian Chen 《World Journal of Stem Cells》 2025年第2期1-16,共16页
Skeletal muscle atrophy results from disruptions in the growth and metabolism of striated muscle,leading to a reduction or loss of muscle fibers.This condition not only significantly impacts patients’quality of life ... Skeletal muscle atrophy results from disruptions in the growth and metabolism of striated muscle,leading to a reduction or loss of muscle fibers.This condition not only significantly impacts patients’quality of life but also imposes substantial socioeconomic burdens.The complex molecular mechanisms driving skeletal muscle atrophy contribute to the absence of effective treatment options.Recent advances in stem cell therapy have positioned it as a promising approach for addressing this condition.This article reviews the molecular mechanisms of muscle atrophy and outlines current therapeutic strategies,focusing on mesenchymal stem cells,induced pluripotent stem cells,and their derivatives.Additionally,the challenges these stem cells face in clinical applications are discussed.A deeper understanding of the regenerative potential of various stem cells could pave the way for breakthroughs in the prevention and treatment of muscle atrophy. 展开更多
关键词 Stem cell Muscle atrophy therapy Mesenchymal stem cells Induced pluripotent stem cells EXOSOME
暂未订购
Macular atrophy after combined intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization
2
作者 Jose M Ruiz-Moreno Javier A Montero +1 位作者 Pedro Amat Francisco Lugo 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2010年第2期161-163,共3页
AIMTo report the appearance of choriocapillaris atrophy after combined high dose intravitreal triamcinolone acetonide (TA) and photodynamic therapy (PDT) to treat choroidal neovascularization (CNV) associated with age... AIMTo report the appearance of choriocapillaris atrophy after combined high dose intravitreal triamcinolone acetonide (TA) and photodynamic therapy (PDT) to treat choroidal neovascularization (CNV) associated with age related macular degeneration (AMD). 展开更多
关键词 age related macular degeneration choriocapillaris atrophy intravitreous triamcinolone photodynamic therapy retinal pigment epithelium atrophy
原文传递
Insights into spinal muscular atrophy from molecular biomarkers 被引量:2
3
作者 Xiaodong Xing Xinzhu Liu +6 位作者 Xiandeng Li Mi Li Xian Wu Xiaohui Huang Ajing Xu Yan Liu Jian Zhang 《Neural Regeneration Research》 SCIE CAS 2025年第7期1849-1863,共15页
Spinal muscular atrophy is a devastating motor neuron disease characterized by severe cases of fatal muscle weakness.It is one of the most common genetic causes of mortality among infants aged less than 2 years.Biomar... Spinal muscular atrophy is a devastating motor neuron disease characterized by severe cases of fatal muscle weakness.It is one of the most common genetic causes of mortality among infants aged less than 2 years.Biomarker research is currently receiving more attention,and new candidate biomarkers are constantly being discovered.This review initially discusses the evaluation methods commonly used in clinical practice while briefly outlining their respective pros and cons.We also describe recent advancements in research and the clinical significance of molecular biomarkers for spinal muscular atrophy,which are classified as either specific or non-specific biomarkers.This review provides new insights into the pathogenesis of spinal muscular atrophy,the mechanism of biomarkers in response to drug-modified therapies,the selection of biomarker candidates,and would promote the development of future research.Furthermore,the successful utilization of biomarkers may facilitate the implementation of gene-targeting treatments for patients with spinal muscular atrophy. 展开更多
关键词 biomarkers disease progression gene-targeting therapy NEUROFILAMENTS Nusinersen spinal muscular atrophy(SMA) survival motor neuron therapeutic evaluation treatment outcomes
暂未订购
Refractory lipoatrophy treated with autologous whole blood injection:A case report
4
作者 Wonnam Kim Jun Su Park En Hyung Kim 《World Journal of Clinical Cases》 SCIE 2025年第2期33-38,共6页
BACKGROUND Intramuscular corticosteroid injection may cause adverse effects such as dermal and/or subcutaneous atrophy,alopecia,hypopigmentation,and hyperpigmentation.Although cutaneous atrophy can spontaneously resol... BACKGROUND Intramuscular corticosteroid injection may cause adverse effects such as dermal and/or subcutaneous atrophy,alopecia,hypopigmentation,and hyperpigmentation.Although cutaneous atrophy can spontaneously resolve,several treatment options have been suggested for this condition.CASE SUMMARY In this paper,we report a case of corticosteroid injection induced lipoatrophy treated with autologous whole blood(AWB)injection,as the condition had been unresponsive to fractional laser therapy.A 29-year-old female patient visited the dermatology clinic complaining of skin depression on her right buttock area,which had appeared six months earlier.There had been only subtle improvement at the margins after fractional CO_(2) laser treatment;therefore,after obtaining informed consent from the patient,AWB treatment was initiated.One month after the first AWB injection,the size and depth of the lesion had noticeably improved,and a slight improvement was also observed in discoloration.CONCLUSION Close observation is the initial treatment of choice for steroid induced skin atrophy;however,for patients in need of immediate cosmetic improvement,AWB injection may be a safe and cost-effective alternative. 展开更多
关键词 atrophy CORTICOSTEROID Subcutaneous fat Autologous whole blood injection Laser therapy Case report
暂未订购
脂肪来源间充质干细胞及外泌体对地塞米松诱导肌肉减少症小鼠的治疗作用
5
作者 袁为远 雷秦袆 +6 位作者 李秀琪 卢铁柱 傅子文 梁志丽 季韶洋 李一佳 任宇 《中国组织工程研究》 北大核心 2026年第1期58-67,共10页
背景:肌肉减少症是一种增龄相关的骨骼肌肉量减少、肌肉力量下降和/或躯体功能减退的老年性疾病。目前,针对肌肉减少症的有效治疗手段仍然匮乏,探索新的治疗方法以改善肌肉减少症患者的症状和预后具有重要的临床意义。目的:探讨犬脂肪... 背景:肌肉减少症是一种增龄相关的骨骼肌肉量减少、肌肉力量下降和/或躯体功能减退的老年性疾病。目前,针对肌肉减少症的有效治疗手段仍然匮乏,探索新的治疗方法以改善肌肉减少症患者的症状和预后具有重要的临床意义。目的:探讨犬脂肪来源间充质干细胞及外泌体对地塞米松诱导的小鼠肌肉减少症模型的影响。方法:从犬脂肪组织中分离并培养脂肪间充质干细胞,通过流式细胞术和成骨、成脂肪、成软骨分化实验进行细胞鉴定及功能评估。随后提取脂肪间充质干细胞外泌体,通过透射电镜、Western blot、库尔特纳米单颗粒检测技术对外泌体进行表征。在体外,使用地塞米松诱导C2C12肌管萎缩模型和C2C12衰老模型,观察犬脂肪来源间充质干细胞及外泌体对肌管生长和肌肉萎缩基因表达的影响。在体内,使用地塞米松诱导构建小鼠肌少症模型,腹腔或静脉注射犬脂肪间充质干细胞治疗,通过小鼠转棒行为学研究、组织病理检查、肌肉萎缩基因检测进行疗效评估。结果与结论:①分离的犬脂肪间充质干细胞高表达CD73、CD90、CD105,低表达MHC-Ⅱ、CD14、CD19、CD34、CD45,在体外能够成功分化为成骨、成脂和成软骨细胞;②脂肪间充质干细胞外泌体粒径大小、电镜形态、特异性标志物阳性表达符合鉴定标准;③与地塞米松诱导的萎缩C2C12细胞相比,脂肪间充质干细胞及外泌体治疗后均可促进肌管的恢复和生长,抑制肌肉萎缩相关基因MuRF1和Atrogin-1的表达;④与衰老C2C12细胞组比,脂肪间充质干细胞及外泌体可显著促进衰老细胞肌管的恢复和生长;⑤与对照组小鼠相比,地塞米松诱导的肌少症模型小鼠在棒时间显著减少(P<0.01),脂肪间充质干细胞腹腔和静脉给药后7 d(P<0.01,P<0.01)和10 d(P<0.01,P<0.05)均可显著增加在棒时间,给药后14 d,各治疗组小鼠在棒时间均高于模型组,但无显著差异;⑥与对照组相比,地塞米松组胫前肌肌管面积显著减小(P<0.01),脂肪间充质干细胞腹腔和静脉给药后可显著增加胫前肌肌管横截面积(P<0.05,P<0.01);⑦与地塞米松组相比,脂肪间充质干细胞腹腔和静脉给药可显著抑制MuRF1和Atrogin-1基因表达(P<0.01,P<0.01,P<0.01,P<0.01)。结果表明,脂肪来源间充质干细胞及外泌体可通过抑制肌肉萎缩基因表达,促进萎缩肌管细胞恢复和生长,腹腔和静脉注射脂肪来源间充质干细胞均对肌肉减少症小鼠有良好的治疗作用。 展开更多
关键词 脂肪间充质干细胞 肌少症 细胞治疗 外泌体 衰老 肌肉萎缩 地塞米松
暂未订购
超声引导下诺西那生钠鞘内注射治疗脊髓性肌萎缩症临床总结
6
作者 李文谦 李君晴 邸铁涛 《儿科药学杂志》 2026年第1期34-36,共3页
目的:总结超声在脊髓性肌萎缩症鞘内注射的实践经验。方法:回顾性分析贵州中医药大学第二附属医院3例超声引导下鞘内注射诺西那生钠的脊髓性肌萎缩症患儿临床资料,并检索文献分析讨论超声在低龄、肥胖、脊柱畸形3类患儿椎管内穿刺的可... 目的:总结超声在脊髓性肌萎缩症鞘内注射的实践经验。方法:回顾性分析贵州中医药大学第二附属医院3例超声引导下鞘内注射诺西那生钠的脊髓性肌萎缩症患儿临床资料,并检索文献分析讨论超声在低龄、肥胖、脊柱畸形3类患儿椎管内穿刺的可行性。结果:本研究3例患儿均在超声辅助下安全完成了诺西那生钠鞘内注射,且无并发症发生。结论:超声引导下鞘内注射诺西那生钠治疗脊髓性肌萎缩症患儿具有显著疗效和安全性,尤其在低龄、肥胖、脊柱畸形等穿刺难度较高的患儿中优势显著,值得临床推广应用。 展开更多
关键词 超声 脊髓性肌萎缩 鞘内注射 疾病修正治疗
暂未订购
Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases 被引量:6
7
作者 Yuan Qu Yi Liu +2 位作者 Ahmed Fayyaz Noor Johnathan Tran Rui Li 《Neural Regeneration Research》 SCIE CAS CSCD 2019年第6期931-938,共8页
Common neurodegenerative diseases of the central nervous system are characterized by progressive damage to the function of neurons, even leading to the permanent loss of function. Gene therapy via gene replacement or ... Common neurodegenerative diseases of the central nervous system are characterized by progressive damage to the function of neurons, even leading to the permanent loss of function. Gene therapy via gene replacement or gene correction provides the potential for transformative therapies to delay or possibly stop further progression of the neurodegenerative disease in affected patients. Adeno-associated virus has been the vector of choice in recent clinical trials of therapies for neurodegenerative diseases due to its safety and efficiency in mediating gene transfer to the central nervous system. This review aims to discuss and summarize the progress and clinical applications of adeno-associated virus in neurodegenerative disease in central nervous system. Results from some clinical trials and successful cases of central neurodegenerative diseases deserve further study and exploration. 展开更多
关键词 nerve REGENERATION central nervous system gene therapy NEURODEGENERATIVE DISEASE viral vector ADENO-ASSOCIATED virus Alzheimer’s DISEASE Parkinson’s DISEASE Huntington’s DISEASE amyotrophic lateral SCLEROSIS spinal muscular atrophy neural REGENERATION
暂未订购
Diabetes mellitus in patients with type 1 autoimmune pancreatitis at diagnosis and after corticosteroid therapy 被引量:4
8
作者 Mei-Zi Li Tao Guo +5 位作者 Yun-Lu Feng Sheng-Yu Zhang Xiao-Yin Bai Xi Wu Kai Xu Ai-Ming Yang 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2024年第4期393-398,共6页
Background:A high prevalence of diabetes mellitus(DM)coexisting with autoimmune pancreatitis(AIP)is observed.However,evidence on the circumstances under which corticosteroid therapy(CST)for AIP improves or worsens DM ... Background:A high prevalence of diabetes mellitus(DM)coexisting with autoimmune pancreatitis(AIP)is observed.However,evidence on the circumstances under which corticosteroid therapy(CST)for AIP improves or worsens DM is scarce.This study aimed to demonstrate and identify predictors of DM control under the influence of CST.Methods:Patients diagnosed with type 1 AIP were enrolled from a prospectively maintained cohort and were classified into three groups according to the chronology in which AIP and DM were diagnosed:pre-existing DM(pDM),concurrent DM(cDM),and non-DM(nDM).The responses of DM to CST were assessed when corticosteroid was ceased or tapered to a maintenance dose and classified as‘improvement’and‘non-improvement’(including‘no change’and‘exacerbation’).Results:Among 101 patients with type 1 AIP,52(51.5%)patients were complicated with DM at the time of AIP diagnosis,with 36 patients in the cDM group and 16 patients in the pDM group.The incidences of diffuse pancreatic swelling(72.2%)and pancreatic body/tail involvement(91.7%)were significantly higher in the cDM group than in both the pDM and nDM groups.Of the 52 patients with DM,CST was administered in 48 cases.Multivariate logistic analysis identified that elevated serum gamma-glutamyl transferase(GGT)level at AIP diagnosis[odds ratio(OR)=0.032,95%confidence interval(CI):0.003-0.412,P=0.008]and pancreatic atrophy after CST(OR=0.027,95%CI:0.003-0.295,P=0.003)were negatively associated with DM control improvement.Conclusions:Patients with diffuse pancreatic swelling and pancreatic body/tail involvement in pancreatitis tended to be complicated with cDM at AIP diagnosis.CST exerted a beneficial effect on the clinical course of DM in nearly half of the AIP patients complicated with DM at diagnosis,particularly in those without elevated serum GGT levels at diagnosis and who did not experience pancreatic atrophy after CST. 展开更多
关键词 Type 1 autoimmune pancreatitis Diabetes mellitus Corticosteroid therapy Predictive factor Pancreatic atrophy
暂未订购
An acupuncture meta-analysis for optic atrophy Seven randomized,controlled trials 被引量:1
9
作者 Mailan Liu Lei Lan Yong Tang Fang Zeng Haiyan Yin Mei Huang Fanrong Liang 《Neural Regeneration Research》 SCIE CAS CSCD 2009年第12期994-1001,共8页
OBJECTIVE: To evaluate the efficacy and safety of acupuncture for optic atrophy. DATA SOURCES: A computer-based online search was conducted in Medline (1966-2008), Embase (1986-2008), the Cochrane Library (up t... OBJECTIVE: To evaluate the efficacy and safety of acupuncture for optic atrophy. DATA SOURCES: A computer-based online search was conducted in Medline (1966-2008), Embase (1986-2008), the Cochrane Library (up to 2008), Chinese Biomedical Literature Database (1975-2008), China National Knowledge Infrastructure (1994-2008), VIP Database (1989-2008), Wanfang Database (1980-2008) and the National Research Register for ongoing trials. DATA SELECTION: Randomized, controlled trials addressing acupuncture treatment for patients with optic atrophy were included in this review. Inclusion criteria evaluated all forms of acupuncture therapy, such as filiform needle, electro-acupuncture, laser-acupuncture, acupressure, and auricular-acupuncture. Comparisons between acupuncture therapy and no treatment (blank) or placebo or Chinese medicine or Western medicine, as well as between acupuncture as an adjuvant and other treatments, were included. Exclusion criteria included studies comparing different forms of acupuncture therapy, different manipulations of acupuncture, and different acupuncture prescriptions, as well as non-randomized, controlled trials and animal studies. The domain-based evaluation criteria recommended by the guidelines in Chapter 8 of the Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 was used to assess quality of the included studies. According to the type of outcome index, measurement data as assessed by weighted mean difference or standardized mean difference and 95% confidence interval; numeration data was estimated by relative risk and 95% confidence interval. Heterogeneity was analyzed by Meta-analysis using RevMan 5.0 software. MAIN OUTCOME MEASURES: Improved visual acuity and visual field was sought between treatment and control groups in the included articles. RESULTS: Seven randomized, controlled trials were included after screening and application of inclusion and exclusion criteria. However, the studies were of low methodological quality and lacked comparisons between acupuncture and no treatment or placebo. Applying visual acuity as the outcome index, meta-analysis indicated: the effect of medicine combined with acupuncture was superior to the medicine alone (relative risk = 1.41, 95% confidence interval 1.14-1.70, P 〈 0.01 ), the efficacy of acupuncture was better than medicine alone (relative risk =1.42, 95% confidence interval 1.14-1.77, P 〈 0.01 ). Using visual field as the other outcome index, meta-analysis revealed: effectiveness of acupuncture or acupuncture in combination with medicine was superior to medicine alone (relative risk = 1.47, 95% confidence interval 1.27-1.69, P 〈 0.01 ). The 7 included articles were incorporated in a sensitivity analysis, and the overall effect showed a significant difference (relative risk = 1.35, 95% confidence interval 1.16-1.56, P 〈 0.01). Acupuncture was not associated with any adverse events in any of the studies. CONCLUSION: Acupuncture therapy was determined to be superior to medicine in terms of improved visual acuity and visual field. However, well-designed, randomized, controlled trials with adequate controls and scientific rigor are urgently needed. 展开更多
关键词 acupuncture therapy optic atrophy EFFECTIVENESS META-ANALYSIS
在线阅读 下载PDF
HOW TO TREAT OPTIC ATROPHY WITH ACUPUNCTURE ?
10
作者 张鸥 《World Journal of Acupuncture-Moxibustion》 1997年第4期60-62,共3页
Optic atrophy results mostly from affection by exopathic wind pathogen, insufficiency of Qi and Xue(blood) or hyperactivity of the liver-yang. We choose Qiuhou(EX-HN 7), Jingming(BL1 ), Taiyang(EX-HN 5 ) and Fengchi(G... Optic atrophy results mostly from affection by exopathic wind pathogen, insufficiency of Qi and Xue(blood) or hyperactivity of the liver-yang. We choose Qiuhou(EX-HN 7), Jingming(BL1 ), Taiyang(EX-HN 5 ) and Fengchi(GB 20) as the main acupoints and combine other auxiliary points according to different syndromes. For example, Hegu(LI 4) and Waiguan(TE 5 ) are supplemented for affection by exopathic wind pathogen, Qihai(CV 6), Zusanli(ST 36), Xuehai(SP 10) and Guang-ming(GB 37) for insufficiency of Qi and Xue, and Guanshu(BL 18), Baihui(GV 20), Taixi(KI 3),Sanyinjiao(SP 6) and Guangming(GB 37) for hyperactivity of the liveryang. When Qiuhou(EX-HN 7), Jingming(BL 1 ) and Fenchi(GB 20) punctured, the need1ing direction, angle and depth should be controlled very appropriate for achieving good therapeutic effect. 展开更多
关键词 Department of OPHTHALMOLOGY OPTIC NERVE atrophy ACUPUNCTURE therapy
暂未订购
OBSERVATION ON THE THERAPEUTIC EFFECT OF ACUPUNCTURE ON OPTIC ATROPHY(48 CASES)
11
作者 王瑞华 《World Journal of Acupuncture-Moxibustion》 1996年第2期7-11,共5页
48 cases of optic atrophy were treated with acupuncture. Qiuhou (EX-HN 7), Jing-ming (BL 1), Ganshu (BL 18), Pishu (BL 20), Fengchi (GB 20), Cuanzhu (BL 2), Yiming (EX-HN 14), Guangming (GB 37), Taiyang (EX-HN 5), Yan... 48 cases of optic atrophy were treated with acupuncture. Qiuhou (EX-HN 7), Jing-ming (BL 1), Ganshu (BL 18), Pishu (BL 20), Fengchi (GB 20), Cuanzhu (BL 2), Yiming (EX-HN 14), Guangming (GB 37), Taiyang (EX-HN 5), Yanglao (SI 6), Sibai (ST 2), Tongziliao(GB 1) were selected as main points, of which three to five points were punctured each time, but thefirst two were used necessarily. According to an overall differentiation of symptoms and signs auxiliarypoints were supplemented. The treatment was given once everyday with the manipulations of twirlingneedles plus slow or rapid insertion for reinforcing or reducing to make the needling sensation reach theeye regions. Twelve treatments made a course with an interval of 3 days between the two courses. Itwas shown that 15 cases were markedly effective (3l. 25 % ), 26 improved (54. 17% ), and 7 ineffec-tive (14. 58 % ). The total effective rate was 85.42%. 展开更多
关键词 OPTIC atrophy ACUPUNCTURE therapy
暂未订购
CLINICAL OBSERVATION ON TREATMENT OF 110 CASES OF OPTIC ATROPHY WITH ACUPUNCTURE
12
作者 Wang XuefengLiaoning College of TCM, Shenyang 110032, China Jiang Xiuying, Guan XianqingThe first Affiliated Hospital of China Medical University 《World Journal of Acupuncture-Moxibustion》 1994年第3期32-34,共3页
The author punctured Kuangshang (the medial one third of the supraorbitalmargin ), Jieli (midway between the occipital condyle and apex helix) and Yintang ((EX-HN3 ) asmain points to treat optic atrophy in 164 eyes of... The author punctured Kuangshang (the medial one third of the supraorbitalmargin ), Jieli (midway between the occipital condyle and apex helix) and Yintang ((EX-HN3 ) asmain points to treat optic atrophy in 164 eyes of 110 patients. The results showed that 12 eyes (7.3% ) were cured, 71 eyes (43. 3 % ) remarkably effective, 39 eyes (23. 8 % ) improved and 42 eyes(25. 6 % ) ineffective, with the total effective rate 74. 4 %. 展开更多
关键词 OPTIC atrophy ACUPUNCTURE therapy
暂未订购
Anti-vascular endothelial growth factor and macular atrophy:an unanswered question
13
作者 Adam Wylęgała Edward Wylęgała 《Annals of Eye Science》 2018年第1期403-406,共4页
Does anti-vascular endothelial growth factor(VEGF)therapy lead to geographic atrophy?If so,does the number of injections or the duration of anti-VEGF therapy correlate with the risk of developing geographic atrophy?Wi... Does anti-vascular endothelial growth factor(VEGF)therapy lead to geographic atrophy?If so,does the number of injections or the duration of anti-VEGF therapy correlate with the risk of developing geographic atrophy?With intravitreal injections becoming the most common ophthalmic invasive procedure and an increasingly aging population,these questions really matter. 展开更多
关键词 atrophy INJECTIONS therapy
暂未订购
浅谈视路系统疾病重在“从肝论治”
14
作者 韦企平 孙艳红 《中国中医眼科杂志》 2025年第9期809-812,共4页
视路系统疾病涵盖从视网膜到枕叶视皮层的多种疾病,病因复杂多样。在中医理论中,眼与肝关系密切。本文通过复习古籍文献,从脏腑辨证和经络学说两个方面阐述视路疾病与肝关系密切的理论基础;整理现代临床和基础方面的文献,阐述视路系统... 视路系统疾病涵盖从视网膜到枕叶视皮层的多种疾病,病因复杂多样。在中医理论中,眼与肝关系密切。本文通过复习古籍文献,从脏腑辨证和经络学说两个方面阐述视路疾病与肝关系密切的理论基础;整理现代临床和基础方面的文献,阐述视路系统疾病“从肝论治”的研究现状。继而以皮质盲临证治疗思路为例,提出视路受脏腑气血之濡养,心、肝、肾三经受邪均可累及视路,所以视路系统疾病重在“从肝论治”,但绝非唯肝论治,应以调肝为核心,在清肝、平肝、疏肝、补肝同时兼顾健脾、补肾、养心、利胆,才能获得较好的临床疗效。最后,以当代名老中医巧用逍遥散系列方剂治疗干眼、角膜溃疡、视网膜色素变性等不同眼病的经验,指出从肝论治不仅用于视路疾病,还可拓展至多种眼病。 展开更多
关键词 视路系统 从肝论治 视神经萎缩 青盲
暂未订购
诺西那生钠联合利司扑兰治疗脊髓性肌萎缩症10例并文献复习 被引量:1
15
作者 段浩林 张慈柳 +3 位作者 杨丽芬 何芳 毛蕾蕾 彭镜 《中国当代儿科杂志》 北大核心 2025年第4期458-464,共7页
目的探讨诺西那生钠联合利司扑兰治疗脊髓性肌萎缩症(spinal muscular atrophy,SMA)的有效性和不良反应。方法回顾性分析中南大学湘雅医院儿童医学中心收治的10例诺西那生钠联合利司扑兰治疗的SMA患儿的临床资料。结果10例SMA患儿中,Ⅰ... 目的探讨诺西那生钠联合利司扑兰治疗脊髓性肌萎缩症(spinal muscular atrophy,SMA)的有效性和不良反应。方法回顾性分析中南大学湘雅医院儿童医学中心收治的10例诺西那生钠联合利司扑兰治疗的SMA患儿的临床资料。结果10例SMA患儿中,Ⅰ型4例,Ⅱ型4例,Ⅲ型2例,其中9例首选诺西那生钠单药治疗,1例首选诺西那生钠联合利司扑兰治疗。10例患儿联合治疗的中位时间为10.5个月(范围:0.5~20.0)个月,其中6例联合治疗超过6个月,运动和/或呼吸功能有所改善;余4例联合治疗时长分别为0.5、1.0、1.3和4.0个月,整体改善不显著。联合治疗后,5例患儿出现皮肤变黑,2例腰椎穿刺部位疼痛,1例呕吐,1例痰液增多,1例全天睡眠时间减少,所有不良反应均为轻度,无需药物干预。结论诺西那生钠联合利司扑兰治疗SMA有一定疗效,且未见明显不良反应。 展开更多
关键词 脊髓性肌萎缩症 诺西那生钠 利司扑兰 联合治疗 儿童
暂未订购
邵念方教授治疗脑萎缩临床经验
16
作者 黄玉强 惠妍 《中国中医药现代远程教育》 2025年第9期77-79,共3页
邵念方教授是山东省名老中医,其认为脑萎缩虚为之主,以肾虚为本;并且邪为之标,以痰、瘀为主。邵教授根据肾精不足为本,痰浊、瘀血、气机不畅为标的基本病机,组建补髓健脑汤治疗脑萎缩。该方的基本方药组成为制何首乌、黄精、山萸肉、鹿... 邵念方教授是山东省名老中医,其认为脑萎缩虚为之主,以肾虚为本;并且邪为之标,以痰、瘀为主。邵教授根据肾精不足为本,痰浊、瘀血、气机不畅为标的基本病机,组建补髓健脑汤治疗脑萎缩。该方的基本方药组成为制何首乌、黄精、山萸肉、鹿角胶、茵陈、泽泻、葛根、桃仁、莲子心、肉桂,可达补肾化瘀、养脑开窍之效。随证根据瘀血、气滞、痰浊的偏盛以及不同发展、传变阶段进行加减,每获良效,为临床提供了重要实践指导。 展开更多
关键词 痴呆 脑萎缩 补髓健脑汤 中医药疗法 名医经验 邵念方
暂未订购
脊髓性肌萎缩症疾病修正治疗真实世界研究进展 被引量:1
17
作者 吴献 刘艳 +6 位作者 刘昕竹 黄晓会 马婧 徐阿晶 幸小东 蒋文高 张健 《临床儿科杂志》 北大核心 2025年第1期61-69,共9页
脊髓性肌萎缩症(SMA)是一种遗传性的神经肌肉疾病,会导致患者出现渐进式的肌无力和肌萎缩,严重者甚至死亡。近年来,SMA修正治疗药物的出现,极大地改善了患者的临床症状及提升了患者的生活质量。此类药物的长期有效性和安全性,以及对疗... 脊髓性肌萎缩症(SMA)是一种遗传性的神经肌肉疾病,会导致患者出现渐进式的肌无力和肌萎缩,严重者甚至死亡。近年来,SMA修正治疗药物的出现,极大地改善了患者的临床症状及提升了患者的生活质量。此类药物的长期有效性和安全性,以及对疗效的各种影响因素尚未明确,需进一步监测和研究。本文通过对SMA修正治疗药物的真实世界有效性、安全性研究进行综述,以期对SMA精准化及个体化治疗提供一些新启发及思考。 展开更多
关键词 脊髓性肌萎缩症 疾病修正治疗 有效性 安全性 真实世界研究
暂未订购
不同运动方式促进周围神经损伤后的功能恢复 被引量:3
18
作者 赵晓璇 刘帅祎 +3 位作者 李奇 邢政 李庆雯 褚晓蕾 《中国组织工程研究》 CAS 北大核心 2025年第6期1248-1256,共9页
背景:运动作为一种主动康复的方式可以改善周围神经损伤导致的功能障碍,而不同运动方式针对的病变部位及恢复机制不同。目的:综合分析不同运动方式在周围神经损伤功能恢复中的应用及机制。方法:应用计算机检索中国知网、PubMed数据库建... 背景:运动作为一种主动康复的方式可以改善周围神经损伤导致的功能障碍,而不同运动方式针对的病变部位及恢复机制不同。目的:综合分析不同运动方式在周围神经损伤功能恢复中的应用及机制。方法:应用计算机检索中国知网、PubMed数据库建库时间至2024年1月期间的相关文献,英文检索词为“peripheral nerves injury,spinal cord,exercise,cerebral cortex,muscle atrophy,mirror therapy,blood flow restriction training”,中文检索词为“周围神经损伤,脊髓,大脑皮质,肌肉萎缩,有氧运动,血流限制,镜像运动”,最终纳入77篇文献进行分析。结果与结论:周围神经损伤后会引起其支配骨骼肌萎缩、相应脊髓节段病变、感觉运动皮质重塑等系统性的病理变化。有氧运动可以加强免疫反应,促进神经胶质细胞极化以及神经生长因子的释放,改善功能障碍。血流限制运动可以调节肌肉生长因子的分泌,促进肌肉生长及增强肌肉力量。镜像运动在激活大脑皮质、减少皮质重塑方面有良好的作用。不同运动方式在周围神经损伤功能恢复中具有潜在的益处,然而目前仍存在一些问题和挑战,例如运动方式的选择、运动强度和频率的控制及机制的详细解析等。 展开更多
关键词 周围神经损伤 脊髓 大脑皮质 肌肉萎缩 有氧运动 血流限制 镜像运动 机制
暂未订购
虚拟现实技术在周围神经损伤功能恢复中的应用 被引量:5
19
作者 张舒扬 杜心愉 +3 位作者 赵冬临 邢政 褚晓蕾 李奇 《中国组织工程研究》 CAS 北大核心 2025年第21期4593-4601,共9页
背景:虚拟现实技术是近年来较为热门的一项人机智能交互技术,已被广泛应用于休闲娱乐、职业培训及医疗康复等领域。目的:旨在探索虚拟现实技术与不同疗法联合在周围神经损伤患者功能恢复中的潜力,概述其作用机制,评估其应用效果和前景,... 背景:虚拟现实技术是近年来较为热门的一项人机智能交互技术,已被广泛应用于休闲娱乐、职业培训及医疗康复等领域。目的:旨在探索虚拟现实技术与不同疗法联合在周围神经损伤患者功能恢复中的潜力,概述其作用机制,评估其应用效果和前景,探讨其优势和不足之处,为周围神经损伤后的康复实践提供新的思路和方法。方法:应用计算机检索中国知网、Pub Med数据库建库时间至2024年5月期间的相关文献,英文检索词为“peripheral nerves injury,virtual reality,endoplasmic reticulum stress,muscle atrophy,cerebral cortex,mirror therapy,tendon vibration,treadmill training”,中文检索词为“周围神经损伤,虚拟现实,内质网应激,肌肉萎缩,大脑皮质,镜像疗法,肌腱振动,跑步机训练”,最终纳入68篇文献进行分析。结果与结论:(1)虚拟现实技术作为一种新兴的辅助手段,通过模拟真实环境为患者提供沉浸式的多感官体验,不仅极大地丰富了康复训练的维度,还显著加速了周围神经损伤患者功能恢复进程;虚拟现实技术的作用机制是通过多感官刺激促进皮质可塑性,相邻的皮质区域入侵沉寂区,这些区域对其他输入作出反应或产生新的肌肉激活,从而促进功能恢复。(2)虚拟现实技术已与传统疗法广泛联合,展现出其独特优势。与镜像疗法联合时,虚拟现实的优势是打破了体位的限制,提前康复介入时间点;与肌腱振动联合,虚拟现实技术通过增强视觉和触觉的双重刺激增强运动错觉,显著提高患者的感知和运动能力,但也存在增加对肢体重量感知的问题;与跑步机训练联合,虚拟现实技术进一步发挥其优势,通过多感官刺激模拟现实环境进行平衡和步行功能,但晕动症等问题依旧存在。(3)因此,在实际应用中,由于虚拟现实与镜像疗法、肌腱振动联合都会增强患者运动错觉,更适用于康复早期,而虚拟现实与跑步机训练联合则适用于康复后期,帮助患者更好地回归日常生活。(4)尽管虚拟现实技术在周围神经损伤康复中已经显示出巨大的潜力,但仍存在一些问题和挑战,如晕动症、虚拟现实康复游戏的设计与应用,以及伦理方面的考量,未来的研究应着重解决这些问题,以推动虚拟现实技术在康复领域的进一步发展。 展开更多
关键词 虚拟现实 周围神经损伤 康复 内质网应激 肌肉萎缩 皮质可塑性 镜像疗法 肌腱振动 跑步机训练 机制
在线阅读 下载PDF
SMN1基因复合杂合变异脊髓性肌萎缩症患者疾病修正治疗的临床疗效分析
20
作者 段浩林 张慈柳 +3 位作者 熊娟 庞楠 尹飞 彭镜 《临床儿科杂志》 北大核心 2025年第7期543-548,共6页
目的探讨SMN1基因复合杂合变异所致脊髓性肌萎缩症(SMA)接受疾病修正治疗的临床疗效。方法回顾性收集2例复合杂合变异SMA患儿的临床资料、治疗经过以及随访结果,并结合国内外相关的病例报道进行分析。结果2例患儿均为SMAⅠ型,SMN1基因... 目的探讨SMN1基因复合杂合变异所致脊髓性肌萎缩症(SMA)接受疾病修正治疗的临床疗效。方法回顾性收集2例复合杂合变异SMA患儿的临床资料、治疗经过以及随访结果,并结合国内外相关的病例报道进行分析。结果2例患儿均为SMAⅠ型,SMN1基因存在外显子7杂合缺失和1处微小变异(分别为c.188C>A和c.683T>A)。其中例1为4岁4个月男性患儿,7月龄起病时开始康复训练,1岁6个月接受诺西那生钠治疗,3岁加用利司扑兰联合治疗,3岁10个月停康复。治疗后患儿运动功能缓慢进步,获得翻身至侧位和扶坐能力,目前可扶坐。例2为1岁8个月女性患儿,4月龄起病时开始康复训练,7月龄口服利司扑兰,因皮肤颜色持续变黑,于1岁5个月改为诺西那生钠治疗。药物治疗结合康复训练后患儿运动功能显著进步,获得独坐和扶站运动里程碑,目前可独站7~8秒、跨步。结论疾病修正治疗能改善复合杂合变异SMA患儿的总体预后,并提高患儿的运动功能。 展开更多
关键词 脊髓性肌萎缩症 复合杂合变异 疾病修正治疗 临床疗效 儿童
暂未订购
上一页 1 2 9 下一页 到第
使用帮助 返回顶部